We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,317 hedge funds and large institutions have $33.5B invested in Celgene Corp in 2018 Q4 according to their latest regulatory filings, with 163 funds opening new positions, 382 increasing their positions, 623 reducing their positions, and 195 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more funds holding in top 10

Funds holding in top 10: 3741 (+4)

10% less call options, than puts

Call options by funds: $1.24B | Put options by funds: $1.37B

3% less funds holding

Funds holding: 1,3641,317 (-47)

16% less first-time investments, than exits

New positions opened: 163 | Existing positions closed: 195

28% less capital invested

Capital invested by funds: $46.6B → $33.5B (-$13.1B)

39% less repeat investments, than reductions

Existing positions increased: 382 | Existing positions reduced: 623

Holders
1,317
Holders Change
-47
Holders Change %
-3.45%
% of All Funds
29.34%
Holding in Top 10
41
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+10.81%
% of All Funds
0.91%
New
163
Increased
382
Reduced
623
Closed
195
Calls
$1.24B
Puts
$1.37B
Net Calls
-$134M
Net Calls Change
+$221M
Name Holding Trade Value Shares
Change
Change in
Stake
PDM
226
Penn Davis McFarland
Texas
$13.9M +$2.7M +36,595 +20%
RPAM
227
Rhenman & Partners Asset Management
Sweden
$13.8M +$2.58M +35,000 +19%
Mariner
228
Mariner
Kansas
$13.8M +$7.26M +98,373 +84%
Janney Montgomery Scott
229
Janney Montgomery Scott
Pennsylvania
$13.4M -$1.92M -26,032 -11%
BIM
230
Bogle Investment Management
Massachusetts
$13M +$15M +203,084 New
SC
231
Saturna Capital
Washington
$12.9M -$627K -8,500 -4%
SOMRS
232
State of Michigan Retirement System
Michigan
$12.8M -$694K -9,400 -4%
MIM
233
MetLife Investment Management
New Jersey
$12.8M -$342K -4,634 -2%
SEI Investments
234
SEI Investments
Pennsylvania
$12.7M +$1.24M +16,811 +12%
Capital Fund Management (CFM)
235
Capital Fund Management (CFM)
France
$12.7M +$14.6M +197,750 New
Comerica Bank
236
Comerica Bank
Texas
$12.6M -$446K -6,045 -4%
PTC
237
Philadelphia Trust Company
Pennsylvania
$12.5M -$33K -447 -0.2%
LPL Financial
238
LPL Financial
California
$12.4M -$1.68M -22,749 -11%
BS
239
Banco Santander
Spain
$12.3M
CS
240
Cannell & Spears
New York
$12.3M -$1.39M -18,809 -9%
FA
241
FCG Advisors
New Jersey
$12M -$107K -1,454 -0.8%
HCM
242
Howland Capital Management
Massachusetts
$12M -$3.81M -51,547 -22%
RSCM
243
Rock Springs Capital Management
Maryland
$11.9M -$12.9M -175,250 -49%
SSA
244
Schonfeld Strategic Advisors
New York
$11.7M +$12.2M +165,700 +952%
RFC
245
Regions Financial Corp
Alabama
$11.6M -$470K -6,361 -3%
Federated Hermes
246
Federated Hermes
Pennsylvania
$11.6M -$9.18M -124,354 -41%
SIM
247
Spark Investment Management
New York
$11.5M -$1.81M -24,500 -12%
CFB
248
Cullen/Frost Bankers
Texas
$11.5M -$754K -10,217 -5%
GHA
249
GW Henssler & Associates
Georgia
$11.5M -$138K -1,875 -1%
CIBC Private Wealth Group
250
CIBC Private Wealth Group
Georgia
$11.5M -$1.18M -16,011 -8%

CELG Hedge Fund Activity: Q4 2018 in Review

1,317 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2018, worth a combined $33.5B — down 28% from $46.6B a quarter earlier.

Sellers outnumbered buyers: 195 funds closed out of CELG and 163 opened new positions — a net loss of 32 holders — while 623 trimmed existing stakes and 382 added.

The largest buyer was Millennium Management, adding an estimated $379M. The largest seller was Edgewood Management, cutting an estimated $1.16B.

  • 1,317 institutional investors held Celgene Corp (CELG) as of Q4 2018, down from 1,364 in Q3 2018.
  • Funds reported $33.5B of Celgene Corp stock for Q4 2018, down 28% quarter-over-quarter.
  • 163 funds opened new Celgene Corp positions in Q4 2018 and 195 closed out, a net change of -32 holders.
  • The largest Celgene Corp buyer in Q4 2018 was Millennium Management, an estimated $379M added.
  • The largest Celgene Corp seller in Q4 2018 was Edgewood Management, an estimated $1.16B sold.

Based on aggregated 13F filings for Q4 2018.